Hemispherx Biopharma, Inc.
(NYSE Amex Equities : HEB)

( )
HEB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.73%104.101.1%$1332.57m
GILDGilead Sciences, Inc.
0.04%72.440.9%$675.30m
AMGNAmgen Inc.
-0.45%170.001.1%$499.55m
BIIBBiogen Inc.
0.00%313.971.2%$468.09m
REGNRegeneron Pharmaceuticals, Inc.
-0.79%391.592.7%$363.74m
ALXNAlexion Pharmaceuticals, Inc.
0.49%110.871.9%$288.55m
VRTXVertex Pharmaceuticals Incorporated
-0.36%147.411.9%$237.28m
INCYIncyte Corporation
-0.95%105.472.5%$187.59m
ALNYAlnylam Pharmaceuticals, Inc
0.89%127.5110.6%$184.43m
ILMNIllumina, Inc.
0.25%209.023.5%$165.18m
NKTRNektar Therapeutics
0.13%44.996.1%$146.11m
JUNOJuno Therapeutics, Inc.
1.56%58.6413.5%$138.44m
BMRNBioMarin Pharmaceutical Inc.
0.39%82.884.4%$117.68m
SRPTSarepta Therapeutics, Inc.
1.94%56.1116.8%$117.17m
BLUEBluebird Bio, Inc.
1.90%163.2017.2%$116.94m

Company Profile

Hemispherx Biopharma, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Philadelphia, PA.